CBUS
HealthcareCibus, Inc.
$2.02
+$0.14 (+7.45%)
Jan 5, 2026
Price History (1Y)
Analysis
Cibus, Inc. is a biotechnology company in the healthcare sector with a market capitalization of $109.90M and 157 employees. The company has reported significant financial challenges, with net income totaling -$118,901,000 over the last four quarters, accompanied by an EBITDA loss of $-65,752,000. Free cash flow was also negative at $-51,366,124, indicating a substantial drain on liquidity. The current ratio is 1.28, suggesting that Cibus has sufficient liquid assets to cover short-term liabilities. Cibus's valuation metrics are notable, with a forward P/E of -2.75 and EV/EBITDA of -5.12, indicating a significant discount in the market's assessment of its future earnings potential relative to its current losses. The price-to-book ratio is 2.11, while the price-to-sales ratio stands at 28.97.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Cibus, Inc.
Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients, which enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was founded in 2001 and is headquartered in San Diego, California.
Visit website →Key Statistics
- Market Cap
- $109.90M
- P/E Ratio
- N/A
- 52-Week High
- $3.40
- 52-Week Low
- $1.09
- Avg Volume
- 387.57K
- Beta
- 1.57
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 157